FOCUS: HIV/AIDS
SA's fight against Aids gets major boost – but there’s a catch
South Africans will receive the groundbreaking lenacapavir drug, seen as the best option to help end Aids in the country, thanks to a R520m offer to buy the twice-a-year anti-HIV jab from the Global Fund to Fight Aids, TB and Malaria.
But, writes Mia Malan for Bhekisisa, there’s a snag. The country isn’t getting extra money from the Fund to buy the medicine: it has to use cash from a grant that it has already been awarded and which was cut...